By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences today said that it has signed up a service provider in Asia and a distributor for its PacBio RS system in Korea.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm said that DNA Link will be the first commercial service provider for PacBio RS sequencing in Asia, as well as the first installation of the system in Korea. Seoul-based DNA Link is a contract research service provider for genomics studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.